Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Schedule Study”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00197067
What this trial is testing

Evaluate the Safety and Immunogenicity of GSK Biologicals' Candidate Vaccines RTS,S/AS02D (0.5 mL Dose) and RTS,S/AS02A (0.25 mL Dose) Administered IM According to a 0, 1, 2 Month Vaccination Schedule in Children Aged 3 to 5 Years Living in a Malaria-endemic Region of Mozambique.

Who this might be right for
Malaria
GlaxoSmithKline 200
Testing effectiveness (Phase 2)Study completedNCT00943540
What this trial is testing

Pharmacokinetic and Safety Study of Raltegravir and Atazanavir in a Once Daily Dose Regimen in HIV-1 Infected Patients

Who this might be right for
HIV InfectionHIV Infections
Radboud University Medical Center 20
Early research (Phase 1)Study completedNCT05142306
What this trial is testing

A COVID-19 Study to Evaluate Safety and PK of COVID-HIG Administered Through IM, SC, or IV Routes to SARS-CoV-2 Uninfected Adults

Who this might be right for
SARS-CoV-2 Infection
Emergent BioSolutions 23
Post-approval studies (Phase 4)Study completedNCT00798434
What this trial is testing

Compare the Effectiveness and Safety of Fesoterodine and Placebo in an Elderly Population of Patients Who go to the Toilet Very Frequently Due to Overactive Bladder.

Who this might be right for
Urinary Bladder, Overactive
Pfizer 794
Testing effectiveness (Phase 2)Study completedNCT01835587
What this trial is testing

Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS).

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Celgene 31
Early research (Phase 1)Study completedNCT02491281
What this trial is testing

First-in-human Single Ascending Dose Study of LNA043 in Patients Scheduled for Total Knee Replacement

Who this might be right for
Primary Osteoarthritis Patients Scheduled for Total Knee Replacement Surgery
Novartis Pharmaceuticals 28
Testing effectiveness (Phase 2)Study completedNCT00140400
What this trial is testing

Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Vaccine (Allogeneic Prostate GVAX®) in Patients With Hormone-Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Cell Genesys 50
Early research (Phase 1)UnknownNCT05475210
What this trial is testing

177Lu-DOTA-EB-TATE in Adult Patients With Advanced, Well- Differentiated Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
Molecular Targeting Technologies, Inc. 9
Testing effectiveness (Phase 2)UnknownNCT01701479
What this trial is testing

Long Term Continuous Infusion ch14.18/CHO Plus s.c. Aldesleukin (IL-2)

Who this might be right for
Neuroblastoma
St. Anna Kinderkrebsforschung 288
Early research (Phase 1)WithdrawnNCT01139359
What this trial is testing

Safety Study of Darinaparsin in Combination With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) to Treat Lymphoma

Who this might be right for
Lymphoma
Alaunos Therapeutics
Early research (Phase 1)Ended earlyNCT00680485
What this trial is testing

Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK580416

Who this might be right for
Bacterial InfectionInfections, Bacterial
GlaxoSmithKline 96
Testing effectiveness (Phase 2)Ended earlyNCT00793650
What this trial is testing

Combination High Dose Melphalan and Autologous Peripheral Blood Stem Cell (PBSC) Transplant With Bortezomib for Multiple Myeloma: A Dose and Schedule Finding Study

Who this might be right for
CancerMultiple Myeloma
Emory University 39
Post-approval studies (Phase 4)Looking for participantsNCT04588077
What this trial is testing

Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis

Who this might be right for
Hepatitis BCirrhosis, LiverChronic Liver Disease
Mercy Medical Center 200
Testing effectiveness (Phase 2)Study completedNCT02233712
What this trial is testing

Open-label, Dose-finding Study to Determine Antibody Response to G17DT Treatment in Patients With Gastric Cancer.

Who this might be right for
Gastric Cancer
Cancer Advances Inc. 33
Testing effectiveness (Phase 2)Study completedNCT02117570
What this trial is testing

Investigate A Clostridium Difficile Vaccine In Healthy Adults Aged 50 to 85 Years, Who Will Each Receive 3 Doses Of Vaccine.

Who this might be right for
Clostridium Difficile Associated Disease
Pfizer 185
Testing effectiveness (Phase 2)Study completedNCT00350337
What this trial is testing

Safety and Immunogenicity of Various Formulations of Live Attenuated Tetravalent Dengue Vaccine in Healthy US Adults

Who this might be right for
Dengue
U.S. Army Medical Research and Development Command 86
Testing effectiveness (Phase 2)Study completedNCT00093418
What this trial is testing

S0432 Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+14 more
National Cancer Institute (NCI) 296
Large-scale testing (Phase 3)Study completedNCT01674647
What this trial is testing

Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion

Who this might be right for
Atrial Fibrillation
Bayer 1,504
Early research (Phase 1)Study completedNCT00225121
What this trial is testing

Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of PF-00299804 In Patients With Advanced Solid Tumors

Who this might be right for
Neoplasms
Pfizer 121
Early research (Phase 1)Study completedNCT00454298
What this trial is testing

Study Evaluating AGG-523 in Subjects With Severe Osteoarthritis Requiring Total Knee Replacement

Who this might be right for
Osteoarthritis
Wyeth is now a wholly owned subsidiary of Pfizer 2
Next Page